<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02465073</url>
  </required_header>
  <id_info>
    <org_study_id>56-RW-027</org_study_id>
    <nct_id>NCT02465073</nct_id>
  </id_info>
  <brief_title>The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds</brief_title>
  <official_title>The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Regional Wound Care Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Next Science TM</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Southwest Regional Wound Care Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Determine the effect on wound treatment outcomes using a novel antimicrobial wound gel
      (NXTSC) for the treatment of infected wounds as the sole topical treatment of microbial
      infection at the wound site.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Determine the effect on wound treatment outcomes using a novel antimicrobial wound gel
           (NXTSC) for the treatment of infected wounds as the sole topical treatment of microbial
           infection at the wound site.

        2. Determine the effect on wound treatment outcomes using a novel antimicrobial wound gel
           for the treatment of infected wounds when this gel is used in conjunction with the
           current standard of care infection controls to treat microbial infection at the wound
           site.

        3. Determine the effect on wound treatment outcomes using standard of care treatment.
           (SOC).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Percentage of Patients Who Had a 50% or Greater Wound Size Volume Reduction After 4 Weeks of Treatment With the Next Science Wound Gel, as Compared to Wounds Treated With Standard of Care</measure>
    <time_frame>Percentage after 4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Wound Infection</condition>
  <arm_group>
    <arm_group_label>NXTSC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive the NXTSC gel only. The NXTSC wound gel and its active agents are applied on the wound bed. A synthetic microfiber dressing will be applied to the surface of the wound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NXTSC plus SOC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive the NXTSC wound gel plus Standard of Care. The NXTSC wound gel is applied to the wound bed. Local wound management will consist of diagnosing the wound biofilm and providing specific measures to suppress the wound biofilm to allow host healing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SOC</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will receive Standard of Care only. The Standard of Care is based on wound management to remove wound slough by frequent debridement. Moist interactive wound care with multiple strategies to suppress biofilm is instituted.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NXTSC wound gel</intervention_name>
    <description>Subjects will receive NXTSC wound gel only.</description>
    <arm_group_label>NXTSC</arm_group_label>
    <other_name>NXTSC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NXTSC wound gel plus Standard of Care</intervention_name>
    <description>Subjects will be randomized to the NXTSC wound gel plus Standard of Care of only.</description>
    <arm_group_label>NXTSC plus SOC</arm_group_label>
    <other_name>NXTSC + SOC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard of Care Group</intervention_name>
    <description>Subjects will receive Standard of Care only.</description>
    <arm_group_label>SOC</arm_group_label>
    <other_name>SOC</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must have a full-thickness chronic wound for greater than one month.

          2. The subject must be at least 18 years of age.

          3. The ulcer to be biopsied must be greater than 1 centimeter in area.

          4. The subject must be able to give informed consent.

        Exclusion Criteria:

          1. Medical or emotional risk associated with the potential biopsy that outweighs the risk
             of not taking a biopsy as determined by the investigator.

          2. Those patients that have significant contributions from other disease processes such
             as arterial disease (Ankle Brachial Index [ABI] less than .7, OR Transcutaneous
             Partial Oxygen Pressure [TCpO2 ] less than 20) will be considered to have mixed
             vascular disease producing their wound and will be excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randall D Wolcott, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest Regional Wound Care Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southwest Regional Wound Care Center</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2014</study_first_submitted>
  <study_first_submitted_qc>June 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2015</study_first_posted>
  <results_first_submitted>December 11, 2015</results_first_submitted>
  <results_first_submitted_qc>December 11, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 18, 2016</results_first_posted>
  <last_update_submitted>December 28, 2017</last_update_submitted>
  <last_update_submitted_qc>December 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NXTSC</title>
          <description>This group will receive the NXTSC gel only.
NXTSC wound gel: Subjects will receive NXTSC wound gel only.</description>
        </group>
        <group group_id="P2">
          <title>NXTSC Plus SOC</title>
          <description>This group will receive the NXTSC wound gel plus Standard of Care.
NXTSC wound gel plus Standard of Care: Subjects will be randomized to the NXTSC wound gel plus Standard of Care of only.</description>
        </group>
        <group group_id="P3">
          <title>Standard of Care</title>
          <description>This group will receive Standard of Care only.
Standard of Care Group: Subjects will receive Standard of Care only.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NXTSC</title>
          <description>This group will receive the NXTSC gel only.
NXTSC wound gel: Subjects will receive NXTSC wound gel only.</description>
        </group>
        <group group_id="B2">
          <title>NXTSC Plus SOC</title>
          <description>This group will receive the NXTSC wound gel plus Standard of Care.
NXTSC wound gel plus Standard of Care: Subjects will be randomized to the NXTSC wound gel plus Standard of Care of only.</description>
        </group>
        <group group_id="B3">
          <title>Standard of Care</title>
          <description>This group will receive Standard of Care only.
Standard of Care Group: Subjects will receive Standard of Care only.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="45"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57" lower_limit="31" upper_limit="67"/>
                    <measurement group_id="B2" value="63" lower_limit="39" upper_limit="72"/>
                    <measurement group_id="B3" value="60" lower_limit="23" upper_limit="76"/>
                    <measurement group_id="B4" value="60" lower_limit="23" upper_limit="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Percentage of Patients Who Had a 50% or Greater Wound Size Volume Reduction After 4 Weeks of Treatment With the Next Science Wound Gel, as Compared to Wounds Treated With Standard of Care</title>
        <time_frame>Percentage after 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NXTSC</title>
            <description>This group will receive the NXTSC gel only.
NXTSC wound gel: Subjects will receive NXTSC wound gel only.</description>
          </group>
          <group group_id="O2">
            <title>NXTSC Plus SOC</title>
            <description>This group will receive the NXTSC wound gel plus Standard of Care.
NXTSC wound gel plus Standard of Care: Subjects will be randomized to the NXTSC wound gel plus Standard of Care of only.</description>
          </group>
          <group group_id="O3">
            <title>Standard of Care</title>
            <description>This group will receive Standard of Care only.
Standard of Care Group: Subjects will receive Standard of Care only.</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Patients Who Had a 50% or Greater Wound Size Volume Reduction After 4 Weeks of Treatment With the Next Science Wound Gel, as Compared to Wounds Treated With Standard of Care</title>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="72"/>
                    <measurement group_id="O3" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>NXTSC</title>
          <description>This group will receive the NXTSC gel only.
NXTSC wound gel: Subjects will receive NXTSC wound gel only.</description>
        </group>
        <group group_id="E2">
          <title>NXTSC Plus SOC</title>
          <description>This group will receive the NXTSC wound gel plus Standard of Care.
NXTSC wound gel plus Standard of Care: Subjects will be randomized to the NXTSC wound gel plus Standard of Care of only.</description>
        </group>
        <group group_id="E3">
          <title>Standard of Care</title>
          <description>This group will receive Standard of Care only.
Standard of Care Group: Subjects will receive Standard of Care only.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Randall Wolcott</name_or_title>
      <organization>Southwest Regional Wound Care Center</organization>
      <phone>806-793-8869</phone>
      <email>randy@randallwolcott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

